Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes

Cellular Immunology

Volumn 273, Issue 1, 2012, Pages 41-51

  Brzoza Lewis, Kristina L ^a   Jason Hoth, J ^a   Hiltbold, Elizabeth M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial infection; Cellular recruitment; Chemokines; Inflammatory infiltrate; Listeria monocytogenes; Monocytes; Neutrophil recruitment; Neutrophils; Type I interferon; Type I interferon signaling

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; INTERFERON RECEPTOR;

APOPTOSIS; ARTICLE; BACTERIAL CLEARANCE; BONE MARROW; CONTROLLED STUDY; ENZYME REGULATION; IMMUNE RESPONSE; INFLAMMATORY INFILTRATE; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; EXUDATES AND TRANSUDATES; FEMALE; IMMUNITY, INNATE; INTERFERON-ALPHA; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OLIGOPEPTIDES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERLEUKIN-8B;

BACTERIA (MICROORGANISMS); LISTERIA; LISTERIA MONOCYTOGENES; MUS;

EID: 84856014406     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.11.008     Document Type: Article

References (65)

1. Allerberger F., Wagner M. Listeriosis: a resurgent foodborne infection. Clin Microbiol Infect 2010, 16:16-23.
2. Posfay-Barbe K.M., Wald E.R. Listeriosis. Semin Fetal Neonatal Med 2009, 14:228-233.
3. Pamer E.G. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004, 4:812-823.
4. Bielecki J., Youngman P., Connelly P., Portnoy D.A. Bacillus subtilis expressing a haemolysin gene from Listeria monocytogenes can grow in mammalian cells. Nature 1990, 345:175-176.
5. Stockinger S., Materna T., Stoiber D., Bayr L., Steinborn R., Kolbe T., Unger H., Chakraborty T., Levy D.E., Muller M., Decker T. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 2002, 169:6522-6529.
6. Feng H., Zhang D., Palliser D., Zhu P., Cai S., Schlesinger A., Maliszewski L., Lieberman J. Listeria-infected myeloid dendritic cells produce IFN-{beta}, priming T cell activation. J Immunol 2005, 175:421-432.
7. O'Riordan M., Yi C.H., Gonzales R., Lee K.D., Portnoy D.A. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc Natl Acad Sci USA 2002, 99:13861-13866.
8. Pietras E.M., Saha S.K., Cheng G. The interferon response to bacterial and viral infections. J Endotoxin Res 2006, 12:246-250.
9. Giamarellos-Bourboulis E.J., Raftogiannis M., Antonopoulou A., Baziaka F., Koutoukas P., Savva A., Kanni T., Georgitsi M., Pistiki A., Tsaganos T., Pelekanos N., Athanassia S., Galani L., Giannitsioti E., Kavatha D., Kontopidou F., Mouktaroudi M., Poulakou G., Sakka V., Panagopoulos P., Papadopoulos A., Kanellakopoulou K., Giamarellou H. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 2009, 4:e8393.
10. Shahangian A., Chow E.K., Tian X., Kang J.R., Ghaffari A., Liu S.Y., Belperio J.A., Cheng G., Deng J.C. Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 2009, 119:1910-1920.
11. Tong H.H., Long J.P., Li D., DeMaria T.F. Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb Pathog 2004, 37:193-204.
12. Laver T., Nozell S.E., Benveniste E.N. IFN-beta-mediated inhibition of IL-8 expression requires the ISGF3 components Stat1, Stat2, and IRF-9. J Interferon Cytokine Res 2008, 28:13-23.
13. Comabella M., Imitola J., Weiner H.L., Khoury S.J. Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients. J Neuroimmunol 2002, 126:205-212.
14. O'Connell R.M., Saha S.K., Vaidya S.A., Bruhn K.W., Miranda G.A., Zarnegar B., Perry A.K., Nguyen B.O., Lane T.F., Taniguchi T., Miller J.F., Cheng G. Type I interferon production enhances susceptibility to Listeria monocytogenes infection. J Exp Med 2004, 200:437-445.
15. Carrero J.A., Calderon B., Unanue E.R. Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med 2004, 200:535-540.
16. Auerbuch V., Brockstedt D.G., Meyer-Morse N., O'Riordan M., Portnoy D.A. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 2004, 200:527-533.
17. R. Boxio, C. Bossenmeyer-Pourie, N. Steinckwich, C. Dournon, and O. Nusse, Mouse bone marrow contains large numbers of functionally competent neutrophils, 2004, pp. 604-611.
18. Semerad C.L., Liu F., Gregory A.D., Stumpf K., Link D.C. G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 2002, 17:413-423.
19. Guo R.F., Ward P.A. Role of C5a in inflammatory responses. Annu Rev Immunol 2005, 23:821-852.
20. Kobayashi Y. The role of chemokines in neutrophil biology. Front Biosci 2008, 13:2400-2407.
21. Spitznagel J.K. Bactericidal mechanisms of the granulocyte. Prog Clin Biol Res 1977, 13:103-131.
22. Elsbach P., Weiss J. Oxygen-dependent and oxygen-independent mechanisms of microbicidal activity of neutrophils. Immunol Lett 1985, 11:159-163.
23. C.J. Czuprynski, J.F. Brown, N. Maroushek, R.D. Wagner, and H. Steinberg, Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection, 1994, pp. 1836-1846.
24. A.L. Rakhmilevich, Neutrophils are essential for resolution of primary and secondary infection with Listeria monocytogenes, 1995, pp. 827-831.
25. North R.J., Dunn P.L., Conlan J.W. Murine listeriosis as a model of antimicrobial defense. Immunol Rev 1997, 158:27-36.
26. Conlan J.W., North R.J. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 1994, 179:259-268.
27. Conlan J.W. Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect Immun 1997, 65:630-635.
28. Rogers H.W., Unanue E.R. Neutrophils are involved in acute, nonspecific resistance to Listeria monocytogenes in mice. Infect Immun 1993, 61:5090-5096.
29. Serbina N.V., Hohl T.M., Cherny M., Pamer E.G. Selective expansion of the monocytic lineage directed by bacterial infection. J Immunol 2009, 183:1900-1910.
30. Serbina N.V., Jia T., Hohl T.M., Pamer E.G. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol 2008, 26:421-452.
31. Serbina N.V., Salazar-Mather T.P., Biron C.A., Kuziel W.A., Pamer E.G. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 2003, 19:59-70.
32. Serbina N.V., Pamer E.G. Coordinating innate immune cells to optimize microbial killing. Immunity 2008, 29:672-674.
33. Kurihara T., Warr G., Loy J., Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997, 186:1757-1762.
34. Serbina N.V., Pamer E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006, 7:311-317.
35. Bhatia M., Hegde A. Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury. Regul Pept 2007, 138:40-48.
36. Hayashi S., Kurdowska A., Cohen A.B., Stevens M.D., Fujisawa N., Miller E.J. A synthetic peptide inhibitor for alpha-chemokines inhibits the growth of melanoma cell lines. J Clin Invest 1997, 99:2581-2587.
37. Hayashi S., Yatsunami J., Fukuno Y., Kawashima M., Miller E.J. Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice. Lung 2002, 180:339-348.
38. Lomas-Neira J.L., Chung C.S., Grutkoski P.S., Miller E.J., Ayala A. CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J Leukoc Biol 2004, 76:58-64.
39. Xin L., Vargas-Inchaustegui D.A., Raimer S.S., Kelly B.C., Hu J., Zhu L., Sun J., Soong L. Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J Immunol 2010, 184:7047-7056.
40. Duraiswamy N., Tse Y., Hammerberg C., Kang S., Cooper K.D. Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages. J Invest Dermatol 1994, 103:678-683.
41. M.A. Jagels, and T.E. Hugli, Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow, 1992, pp. 1119-1128.
42. Carrero J.A., Unanue E.R. Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol 2006, 27:497-503.
43. Stockinger S., Decker T. Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 2008, 213:889-897.
44. Maus U., von Grote K., Kuziel W.A., Mack M., Miller E.J., Cihak J., Stangassinger M., Maus R., Schlondorff D., Seeger W., Lohmeyer J. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am J Respir Crit Care Med 2002, 166:268-273.
45. Miller E.J., Cohen A.B., Peterson B.T. Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflamm Res 1996, 45:393-397.
46. Fujisawa N., Hayashi S., Kurdowska A., Carr F.K., Miller E.J. Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate. Cytokine 1999, 11:231-238.
47. Hoth J.J., Wells J.D., Brownlee N.A., Hiltbold E.M., Meredith J.W., McCall C.E., Yoza B.K. Toll-like receptor 4-dependent responses to lung injury in a murine model of pulmonary contusion. Shock 2009, 31:376-381.
48. Weigent D.A., Huff T.L., Peterson J.W., Stanton G.J., Baron S. Role of interferon in streptococcal infection in the mouse. Microb Pathog 1986, 1:399-407.
49. Schiavoni G., Mauri C., Carlei D., Belardelli F., Pastoris M.C., Proietti E. Type I IFN protects permissive macrophages from Legionella pneumophila infection through an IFN-gamma-independent pathway. J Immunol 2004, 173:1266-1275.
50. Freudenberg M.A., Merlin T., Kalis C., Chvatchko Y., Stubig H., Galanos C. Cutting edge: a murine, IL-12-independent pathway of IFN-gamma induction by gram-negative bacteria based on STAT4 activation by Type I IFN and IL-18 signaling. J Immunol 2002, 169:1665-1668.
51. Gold J.A., Hoshino Y., Hoshino S., Jones M.B., Nolan A., Weiden M.D. Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect Immun 2004, 72:1291-1297.
52. Mancuso G., Midiri A., Biondo C., Beninati C., Zummo S., Galbo R., Tomasello F., Gambuzza M., Macri G., Ruggeri A., Leanderson T., Teti G. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 2007, 178:3126-3133.
53. Karaghiosoff M., Steinborn R., Kovarik P., Kriegshauser G., Baccarini M., Donabauer B., Reichart U., Kolbe T., Bogdan C., Leanderson T., Levy D., Decker T., Muller M. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003, 4:471-477.
54. Mahieu T., Park J.M., Revets H., Pasche B., Lengeling A., Staelens J., Wullaert A., Vanlaere I., Hochepied T., Van Roy F., Karin M., Libert C. The wild-derived inbred mouse strain SPRET/Ei is resistant to LPS and defective in IFN-beta production. Proc Natl Acad Sci USA 2006, 103:2292-2297.
55. Carrero J.A., Calderon B., Unanue E.R. Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med 2006, 203:933-940.
56. Jia T., Leiner I., Dorothee G., Brandl K., Pamer E.G. MyD88 and Type I interferon receptor-mediated chemokine induction and monocyte recruitment during Listeria monocytogenes infection. J Immunol 2009, 183:1271-1278.
57. Rayamajhi M., Humann J., Penheiter K., Andreasen K., Lenz L.L. Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma. J Exp Med 2010, 207:327-337.
58. Carrero J.A., Unanue E.R. Impact of lymphocyte apoptosis on the innate immune stages of infection. Immunol Res 2007, 38:333-341.
59. N.V. Serbina, T.M. Hohl, M. Cherny, and E.G. Pamer, Selective Expansion of the Monocytic Lineage Directed by Bacterial Infection, 2009, pp. 1900-1910.
60. Serbina N.V., Kuziel W., Flavell R., Akira S., Rollins B., Pamer E.G. Sequential MyD88-independent and -dependent activation of innate immune responses to intracellular bacterial infection. Immunity 2003, 19:891-901.
61. Nozell S., Laver T., Patel K., Benveniste E.N. Mechanism of IFN-beta-mediated inhibition of IL-8 gene expression in astroglioma cells. J Immunol 2006, 177:822-830.
62. Navarini A.A., Lang K.S., Verschoor A., Recher M., Zinkernagel A.S., Nizet V., Odermatt B., Hengartner H., Zinkernagel R.M. Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections. Proc Natl Acad Sci USA 2009, 106:7107-7112.
63. Navarini A.A., Recher M., Lang K.S., Georgiev P., Meury S., Bergthaler A., Flatz L., Bille J., Landmann R., Odermatt B., Hengartner H., Zinkernagel R.M. Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses. Proc Natl Acad Sci USA 2006, 103:15535-15539.
64. Diavatopoulos D.A., Short K.R., Price J.T., Wilksch J.J., Brown L.E., Briles D.E., Strugnell R.A., Wijburg O.L. Influenza A virus facilitates Streptococcus pneumoniae transmission and disease. FASEB J. 2010, 24:1789-1798.
65. Small C.L., Shaler C.R., McCormick S., Jeyanathan M., Damjanovic D., Brown E.G., Arck P., Jordana M., Kaushic C., Ashkar A.A., Xing Z. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 2011, 184:2048-2056.